Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1997-3-4
|
pubmed:abstractText |
The aim of this study was to investigate the presence and the fine specificity of anti-CD4 autoantibodies in seronegative subjects sexually exposed to HIV-1. Anti-CD4 autoantibodies were previously detected in a fraction of HIV-1-seropositive individuals. Whole sera, purified IgG fractions, and supernatants of EBV-transformed lymphoblastoid cell lines were analyzed by means of ELISA, Western blot, and by competition assays using monoclonal antibodies with known fine specificities. Anti-CD4 antibodies were found in 6 of 18 individuals exposed to HIV-1 infection and who have been persistently seronegative. These antibodies inhibited HIV-1-driven syncytium formation, did not interfere with the CD4-gp120 interaction, and competed for CD4 binding with two of three anti-CD4 monoclonals with known fine specificities. Moreover, autoantibodies with the same fine specificities were found in the supernatants of oligoclonal EBV-transformed B cell lines derived from these individuals. At variance, in the HIV-1-positive patients included in our study, the anti-CD4 antibody response was directed to a broader panel of epitopes, including those involved in CD4-gp120 interactions. In conclusion, anti-CD4 antibodies specific for defined epitopes of the CD4 molecule are generated in the course of an early immune response to HIV-1 antigens in the absence of other signs of infection, as they can be detected by conventional methods. These autoantibodies may play a protective role either alone or in association with other cellular and humoral factors.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0889-2229
|
pubmed:author |
pubmed-author:AbecasisCC,
pubmed-author:BerettaAA,
pubmed-author:BorgonovoBB,
pubmed-author:BurasteroS ESE,
pubmed-author:CeladaFF,
pubmed-author:De SantisCC,
pubmed-author:GaffiDD,
pubmed-author:GasparriAA,
pubmed-author:LazzarinAA,
pubmed-author:LopalcoLL,
pubmed-author:RobbioniPP,
pubmed-author:SiccardiA GAG,
pubmed-author:TambussiGG
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
12
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
273-80
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:8906987-Antigens, CD4,
pubmed-meshheading:8906987-Autoantibodies,
pubmed-meshheading:8906987-Blotting, Western,
pubmed-meshheading:8906987-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:8906987-HIV Seronegativity,
pubmed-meshheading:8906987-HIV Seropositivity,
pubmed-meshheading:8906987-HIV-1,
pubmed-meshheading:8906987-Humans,
pubmed-meshheading:8906987-Male,
pubmed-meshheading:8906987-Risk Factors
|
pubmed:year |
1996
|
pubmed:articleTitle |
Autoantibodies to CD4 in HIV type 1-exposed seronegative individuals.
|
pubmed:affiliation |
San Raffaele Scientific Institute, Milan, Italy.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|